Judith Wienke

1.1k citations
25 papers · 490 indexed · h-index 12
Topics
Neuroblastoma Research and Treatments (10 papers)CAR-T cell therapy research (8 papers)Inflammatory Myopathies and Dermatomyositis (7 papers)

In The Last Decade

Judith Wienke

22 papers receiving 489 citations

Peers

Judith Wienke
Comparison fields: 5 of 64
  • Immunology 207
  • Neurology 150
  • Epidemiology 125
  • Molecular Biology 124
  • Oncology 112
Replace Dale Frank with:
Dale Frank United States
Jayesh M. Pandya Sweden
Minoru Kojima Japan
Lénaïg Mescam-Mancini France
Florence Armstrong France
Naoki Kurita Japan
Dana P. Ascherman United States
Mónica García‐Cosío Spain
Bruce Addis United Kingdom
Yoshinao Oda Japan
Judith Wienke relative to Dale Frank United States Dale Frank's profile →
Citations per field
00.5×5.2×
Dale Frank · 1×
Citations per year

Countries citing papers authored by Judith Wienke

Since Specialization
Citations

This map shows the geographic impact of Judith Wienke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Judith Wienke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Judith Wienke more than expected).

Fields of papers citing papers by Judith Wienke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Judith Wienke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Judith Wienke. The network helps show where Judith Wienke may publish in the future.

Co-authorship network of co-authors of Judith Wienke

This figure shows the co-authorship network connecting the top 25 collaborators of Judith Wienke. A scholar is included among the top collaborators of Judith Wienke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Judith Wienke. Judith Wienke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 1
4 0
5 5
6 5
7 22
8 12
9 9
10 31
11 17
12 4
13 2
14 129
15 28
16 29
17 21
18 50
19 57
20 24

About Judith Wienke

Judith Wienke is a scholar working on Gastroenterology, Neurology and Immunology, having authored 25 papers that have together received 490 indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (10 papers), CAR-T cell therapy research (8 papers) and Inflammatory Myopathies and Dermatomyositis (7 papers). The work is most often cited by research in Neurology (150 citations), Immunology (207 citations) and Rheumatology (103 citations). Judith Wienke has collaborated with scholars based in Netherlands, United Kingdom and Germany. Frequent co-authors include Femke van Wijk, Jan J. Molenaar, Miranda P. Dierselhuis, Stefan Nierkens, Godelieve A.M. Tytgat, Annette Künkele, Annet van Royen‐Kerkhof, Claire T. Deakin, Lucy R. Wedderburn and Ulrich Junge. Their work appears in journals such as The Journal of Immunology, Frontiers in Immunology and Annals of the Rheumatic Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026